Ian W. Campbell, Kerstin M. G. Brand, Ulrike Gottwald-Hostalek, Julian Dettenbach. Evaluating Cost-Effectiveness in Relation to the Supporting Clinical Evidence Across the Type 2 Diabetes Continuum: A Review of Metformin and SGLT2is. // Advances in Therapy. – 2026. – DOI: 10.1007/s12325-026-03592-6. – URL: https://doi.org/10.1007/s12325-026-03592-6
Ian W. Campbell, Kerstin M. G. Brand, Ulrike Gottwald-Hostalek, & Julian Dettenbach (2026). Evaluating Cost-Effectiveness in Relation to the Supporting Clinical Evidence Across the Type 2 Diabetes Continuum: A Review of Metformin and SGLT2is. Advances in Therapy. https://doi.org/10.1007/s12325-026-03592-6
Ian W. Campbell, et al. “Evaluating Cost-Effectiveness in Relation to the Supporting Clinical Evidence Across the Type 2 Diabetes Continuum: A Review of Metformin and SGLT2is.” Advances in Therapy, 2026. doi:10.1007/s12325-026-03592-6.
@article{Campbell2026,
title = {Evaluating Cost-Effectiveness in Relation to the Supporting Clinical Evidence Across the Type 2 Diabetes Continuum: A Review of Metformin and SGLT2is},
author = {Campbell, Ian W. and Brand, Kerstin M. G. and Gottwald-Hostalek, Ulrike and Dettenbach, Julian},
journal = {Advances in Therapy},
year = {2026},
doi = {10.1007/s12325-026-03592-6},
url = {https://doi.org/10.1007/s12325-026-03592-6}
}